Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome

Implications for increased cardiovascular risk

I. Jialal, S. Devaraj, U. Singh, B. A. Huet

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Objective: Metabolic syndrome (MetS) is characterized by low-grade inflammation and confers an increased risk for cardiovascular disease. Endothelial progenitor cells (EPCs) are a measure of vascular health and are decreased in patients with various risk factors for cardiovascular disease (CVD). There is a paucity of data examining the EPC status especially in terms of their functionality in MetS subjects without diabetes or cardiovascular disease. We aimed to enumerate and functionally characterize EPCs in subjects with MetS in comparison to healthy controls. Methods: The study was performed at the University of California Davis Medical Center. Healthy controls (n=31) and MetS (n=46) subjects were included in the study. EPCs were enumerated in fasting blood by KDR/CD34 dual positivity. Functionality was assessed by the colony forming units (CFU) assay, migration and tubule formation. Results: Subjects with MetS had significantly decreased number of EPCs compared to control subjects. Furthermore, EPCs from MetS subjects depicted significantly impaired clonogenic capacity, i.e., decreased colony forming units, and impaired capacity to incorporate into tubular structures suggesting functional impairment of EPCs from MetS subjects. Conclusions: We make the novel observation that MetS subjects without diabetes or CVD have decreased EPC number and impaired functionality as compared to control subjects. These findings could contribute to the increased CV risk in this population.

Original languageEnglish (US)
Pages (from-to)297-302
Number of pages6
JournalAtherosclerosis
Volume211
Issue number1
DOIs
StatePublished - Jul 2010

Fingerprint

Cardiovascular Diseases
Colony-Forming Units Assay
Endothelial Progenitor Cells
Blood Vessels
Fasting
Stem Cells
Cell Count
Observation
Inflammation
Health
Population

Keywords

  • CD34+KDR+ cells
  • CRP
  • EPC functions
  • Metabolic Syndrome

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome : Implications for increased cardiovascular risk. / Jialal, I.; Devaraj, S.; Singh, U.; Huet, B. A.

In: Atherosclerosis, Vol. 211, No. 1, 07.2010, p. 297-302.

Research output: Contribution to journalArticle

@article{e9ea81a8b80f4c5bb194fb3723e2f1fe,
title = "Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: Implications for increased cardiovascular risk",
abstract = "Objective: Metabolic syndrome (MetS) is characterized by low-grade inflammation and confers an increased risk for cardiovascular disease. Endothelial progenitor cells (EPCs) are a measure of vascular health and are decreased in patients with various risk factors for cardiovascular disease (CVD). There is a paucity of data examining the EPC status especially in terms of their functionality in MetS subjects without diabetes or cardiovascular disease. We aimed to enumerate and functionally characterize EPCs in subjects with MetS in comparison to healthy controls. Methods: The study was performed at the University of California Davis Medical Center. Healthy controls (n=31) and MetS (n=46) subjects were included in the study. EPCs were enumerated in fasting blood by KDR/CD34 dual positivity. Functionality was assessed by the colony forming units (CFU) assay, migration and tubule formation. Results: Subjects with MetS had significantly decreased number of EPCs compared to control subjects. Furthermore, EPCs from MetS subjects depicted significantly impaired clonogenic capacity, i.e., decreased colony forming units, and impaired capacity to incorporate into tubular structures suggesting functional impairment of EPCs from MetS subjects. Conclusions: We make the novel observation that MetS subjects without diabetes or CVD have decreased EPC number and impaired functionality as compared to control subjects. These findings could contribute to the increased CV risk in this population.",
keywords = "CD34+KDR+ cells, CRP, EPC functions, Metabolic Syndrome",
author = "I. Jialal and S. Devaraj and U. Singh and Huet, {B. A.}",
year = "2010",
month = "7",
doi = "10.1016/j.atherosclerosis.2010.01.036",
language = "English (US)",
volume = "211",
pages = "297--302",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome

T2 - Implications for increased cardiovascular risk

AU - Jialal, I.

AU - Devaraj, S.

AU - Singh, U.

AU - Huet, B. A.

PY - 2010/7

Y1 - 2010/7

N2 - Objective: Metabolic syndrome (MetS) is characterized by low-grade inflammation and confers an increased risk for cardiovascular disease. Endothelial progenitor cells (EPCs) are a measure of vascular health and are decreased in patients with various risk factors for cardiovascular disease (CVD). There is a paucity of data examining the EPC status especially in terms of their functionality in MetS subjects without diabetes or cardiovascular disease. We aimed to enumerate and functionally characterize EPCs in subjects with MetS in comparison to healthy controls. Methods: The study was performed at the University of California Davis Medical Center. Healthy controls (n=31) and MetS (n=46) subjects were included in the study. EPCs were enumerated in fasting blood by KDR/CD34 dual positivity. Functionality was assessed by the colony forming units (CFU) assay, migration and tubule formation. Results: Subjects with MetS had significantly decreased number of EPCs compared to control subjects. Furthermore, EPCs from MetS subjects depicted significantly impaired clonogenic capacity, i.e., decreased colony forming units, and impaired capacity to incorporate into tubular structures suggesting functional impairment of EPCs from MetS subjects. Conclusions: We make the novel observation that MetS subjects without diabetes or CVD have decreased EPC number and impaired functionality as compared to control subjects. These findings could contribute to the increased CV risk in this population.

AB - Objective: Metabolic syndrome (MetS) is characterized by low-grade inflammation and confers an increased risk for cardiovascular disease. Endothelial progenitor cells (EPCs) are a measure of vascular health and are decreased in patients with various risk factors for cardiovascular disease (CVD). There is a paucity of data examining the EPC status especially in terms of their functionality in MetS subjects without diabetes or cardiovascular disease. We aimed to enumerate and functionally characterize EPCs in subjects with MetS in comparison to healthy controls. Methods: The study was performed at the University of California Davis Medical Center. Healthy controls (n=31) and MetS (n=46) subjects were included in the study. EPCs were enumerated in fasting blood by KDR/CD34 dual positivity. Functionality was assessed by the colony forming units (CFU) assay, migration and tubule formation. Results: Subjects with MetS had significantly decreased number of EPCs compared to control subjects. Furthermore, EPCs from MetS subjects depicted significantly impaired clonogenic capacity, i.e., decreased colony forming units, and impaired capacity to incorporate into tubular structures suggesting functional impairment of EPCs from MetS subjects. Conclusions: We make the novel observation that MetS subjects without diabetes or CVD have decreased EPC number and impaired functionality as compared to control subjects. These findings could contribute to the increased CV risk in this population.

KW - CD34+KDR+ cells

KW - CRP

KW - EPC functions

KW - Metabolic Syndrome

UR - http://www.scopus.com/inward/record.url?scp=77953781202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953781202&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2010.01.036

DO - 10.1016/j.atherosclerosis.2010.01.036

M3 - Article

VL - 211

SP - 297

EP - 302

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -